Etop Ibcsg Partners Foundation

This trial is testing whether adding a daily pill called niraparib to standard immunotherapy maintenance can help control advanced small cell lung cancer for longer. It is for patients whose cancer has a specific biomarker (SLFN11-positive) and has not worsened after initial chem…

This study aims to find out if adding a precise, targeted form of radiation to the brain (called stereotactic radiosurgery) to standard drug treatments works better than the drugs alone. It is for adults with melanoma or non-small cell lung cancer that has recently spread to the …

This international trial is for people with a certain stage of non-small cell lung cancer that can be surgically removed. It tests whether adding a year of immunotherapy (durvalumab) after surgery provides extra benefit, compared to just observation, for patients who have already…

This study is testing if a drug called cemiplimab, a type of immunotherapy, can help prevent non-small cell lung cancer from coming back after it has been surgically removed. It is for patients with stage II or IIIA lung cancer who have had surgery but have decided not to get, or…